Literature DB >> 20951965

Structure-function analysis of the human JC polyomavirus establishes the LSTc pentasaccharide as a functional receptor motif.

Ursula Neu1, Melissa S Maginnis, Angelina S Palma, Luisa J Ströh, Christian D S Nelson, Ten Feizi, Walter J Atwood, Thilo Stehle.   

Abstract

The human pan> class="Species">JC polyomavirus (JCV) causes a fatal demyelinating disease, progressive multifocal leukoencephalopathy (PML), in immunocompromised individuals. Current treatment options for PML are inadequate. Sialylated oligosaccharides and the serotonin receptor are known to be necessary for JCV entry, but the molecular interactions underlying JCV attachment remain unknown. Using glycan array screening and viral infectivity assays, we identify a linear sialylated pentasaccharide with the sequence NeuNAc-α2,6-Gal-β1,4-GlcNAc-β1,3-Gal-β1,4-Glc (LSTc) present on host glycoproteins and glycolipids as a specific JCV recognition motif. The crystal structure of the JCV capsid protein VP1 was solved alone and in complex with LSTc. It reveals extensive interactions with the terminal sialic acid of the LSTc motif and specific recognition of an extended conformation of LSTc. Mutations in the JCV oligosaccharide-binding sites abolish cell attachment, viral spread, and infectivity, further validating the importance of this interaction. Our findings provide a powerful platform for the development of antiviral compounds.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20951965      PMCID: PMC2957469          DOI: 10.1016/j.chom.2010.09.004

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  49 in total

1.  Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease.

Authors:  Gert Van Assche; Marc Van Ranst; Raf Sciot; Bénédicte Dubois; Séverine Vermeire; Maja Noman; Jannick Verbeeck; Karel Geboes; Wim Robberecht; Paul Rutgeerts
Journal:  N Engl J Med       Date:  2005-06-09       Impact factor: 91.245

Review 2.  Human demyelinating disease and the polyomavirus JCV.

Authors:  K Khalili; M K White
Journal:  Mult Scler       Date:  2006-04       Impact factor: 6.312

3.  Electron microscopic observations on a case of progressive multifocal leukoencephalopathy.

Authors:  L Silverman; L J Rubinstein
Journal:  Acta Neuropathol       Date:  1965-11-18       Impact factor: 17.088

4.  GM1 structure determines SV40-induced membrane invagination and infection.

Authors:  Helge Ewers; Winfried Römer; Alicia E Smith; Kirsten Bacia; Serge Dmitrieff; Wengang Chai; Roberta Mancini; Jürgen Kartenbeck; Valérie Chambon; Ludwig Berland; Ariella Oppenheim; Günter Schwarzmann; Ten Feizi; Petra Schwille; Pierre Sens; Ari Helenius; Ludger Johannes
Journal:  Nat Cell Biol       Date:  2009-12-20       Impact factor: 28.824

5.  The human polyomavirus, JCV, does not share receptor specificity with SV40 on human glial cells.

Authors:  C K Liu; A P Hope; W J Atwood
Journal:  J Neurovirol       Date:  1998-02       Impact factor: 2.643

6.  Structure of murine polyomavirus complexed with an oligosaccharide receptor fragment.

Authors:  T Stehle; Y Yan; T L Benjamin; S C Harrison
Journal:  Nature       Date:  1994-05-12       Impact factor: 49.962

Review 7.  Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project.

Authors:  Kenneth R Carson; Daniele Focosi; Eugene O Major; Mario Petrini; Elizabeth A Richey; Dennis P West; Charles L Bennett
Journal:  Lancet Oncol       Date:  2009-08       Impact factor: 41.316

8.  Construction of a novel JCV/SV40 hybrid virus (JCSV) reveals a role for the JCV capsid in viral tropism.

Authors:  Benjamin J Chen; Walter J Atwood
Journal:  Virology       Date:  2002-09-01       Impact factor: 3.616

9.  Progressive multifocal leukoencephalopathy after natalizumab monotherapy.

Authors:  Hans Lindå; Anders von Heijne; Eugene O Major; Caroline Ryschkewitsch; Johan Berg; Tomas Olsson; Claes Martin
Journal:  N Engl J Med       Date:  2009-09-10       Impact factor: 91.245

10.  Ligands for the beta-glucan receptor, Dectin-1, assigned using "designer" microarrays of oligosaccharide probes (neoglycolipids) generated from glucan polysaccharides.

Authors:  Angelina S Palma; Ten Feizi; Yibing Zhang; Mark S Stoll; Alexander M Lawson; Esther Díaz-Rodríguez; María Asunción Campanero-Rhodes; Júlia Costa; Siamon Gordon; Gordon D Brown; Wengang Chai
Journal:  J Biol Chem       Date:  2005-12-21       Impact factor: 5.157

View more
  107 in total

Review 1.  Progressive multifocal leukoencephalopathy: clinical and molecular aspects.

Authors:  Eleonora Tavazzi; Martyn K White; Kamel Khalili
Journal:  Rev Med Virol       Date:  2011-09-21       Impact factor: 6.989

2.  Photogenerated lectin sensors produced by thiol-ene/yne photo-click chemistry in aqueous solution.

Authors:  Oscar Norberg; Irene H Lee; Teodor Aastrup; Mingdi Yan; Olof Ramström
Journal:  Biosens Bioelectron       Date:  2012-01-28       Impact factor: 10.618

3.  Synthetic antibodies and peptides recognizing progressive multifocal leukoencephalopathy-specific point mutations in polyomavirus JC capsid viral protein 1.

Authors:  Gang Chen; Leonid Gorelik; Kenneth J Simon; Alevtina Pavlenco; Anne Cheung; Margot Brickelmaier; Ling Ling Chen; Ping Jin; Paul H Weinreb; Sachdev S Sidhu
Journal:  MAbs       Date:  2015-04-16       Impact factor: 5.857

4.  Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy.

Authors:  Ivan Jelcic; Benoit Combaluzier; Ilijas Jelcic; Wolfgang Faigle; Luzia Senn; Brenda J Reinhart; Luisa Ströh; Roger M Nitsch; Thilo Stehle; Mireia Sospedra; Jan Grimm; Roland Martin
Journal:  Sci Transl Med       Date:  2015-09-23       Impact factor: 17.956

5.  Infectious Entry of Merkel Cell Polyomavirus.

Authors:  Miriam Becker; Melissa Dominguez; Lilo Greune; Laura Soria-Martinez; Moritz M Pfleiderer; Rachel Schowalter; Christopher B Buck; Bärbel S Blaum; M Alexander Schmidt; Mario Schelhaas
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

Review 6.  The sweet spot: defining virus-sialic acid interactions.

Authors:  Jennifer E Stencel-Baerenwald; Kerstin Reiss; Dirk M Reiter; Thilo Stehle; Terence S Dermody
Journal:  Nat Rev Microbiol       Date:  2014-09-29       Impact factor: 60.633

7.  JC Polyomavirus Entry by Clathrin-Mediated Endocytosis Is Driven by β-Arrestin.

Authors:  Colleen L Mayberry; Ashley N Soucy; Conner R Lajoie; Jeanne K DuShane; Melissa S Maginnis
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

8.  Adipocyte Plasma Membrane Protein (APMAP) promotes JC Virus (JCPyV) infection in human glial cells.

Authors:  Sheila A Haley; Bethany A O'Hara; Walter J Atwood
Journal:  Virology       Date:  2020-06-07       Impact factor: 3.616

Review 9.  Immune surveillance and response to JC virus infection and PML.

Authors:  Sarah Beltrami; Jennifer Gordon
Journal:  J Neurovirol       Date:  2013-12-03       Impact factor: 2.643

10.  Gallic acid-based small-molecule inhibitors of JC and BK polyomaviral infection.

Authors:  Bethany A O'Hara; Chamila Rupasinghe; Achani Yatawara; Gabriel Gaidos; Dale F Mierke; Walter J Atwood
Journal:  Virus Res       Date:  2014-06-21       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.